CD8+ cytotoxic T cells, pivotal in tumor shrinkage, recognize and eliminate cancer cells presenting tumor-specific antigens, albeit often encountering exhaustion due to inhibitory receptor ligands like PD-L1 or PD-L2 [8,9]. The gene discussed is PDCD1LG2; the disease is neoplasm.